Company intelligence / Profile preview
Finlay Vaccine Institute
Havana, La Habana, Cubafinlay.edu.cu ↗
- Ownership
- Private
- Employees
- ~970
- Development stage
- Commercial
01
Overview
The institute has developed multiple approved vaccines, including those against meningococcal disease and leptospirosis. Its COVID vaccine candidates, notably Soberana series (Soberana 01, Soberana 02, Soberana Plus), have shown high efficacy (>90%) in clinical trials. The heterologous schedule with SOBERANA Plus demonstrated strong immunogenicity and safety profiles with long-lasting antibody responses[5][6]. Technology transfer agreements have enabled international production of its COVID vaccines.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Prophylactic vaccinesGenetically engineered subunit vaccines
- Industry
- Biotech
02
Drug pipeline
14 assets13 more assets in the full pipeline.
Request access →03
Partnerships
Pasteur Institute of Iran (technology transfer for Soberana 02/Soberana Plus)BioCubaFarma group collaborations
Beyond the preview
Go deeper on Finlay Vaccine Institute.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Finlay Vaccine Institute.